Add time:08/16/2019 Source:sciencedirect.com
Current local treatments for cutaneous human immunodeficiency virus—associated Kaposi's sarcoma lesions can be less than ideal. Photodynamic therapy (PDT) consisting of a photoreactive drug and a laser light source has been used to treat a variety of neoplasms. This paper presents the case report of a 36-year-old man with multiple Kaposi's sarcoma lesions. Using the photosensitizer tin ethyl etiopurpurin and red light activation 24 hours postinfusion, we achieved excellent subjective and objective response on follow-up examinations to 20 weeks posttreatment. Photodynamic therapy is an outpatient procedure that is well tolerated and highly effective for the treatment of Kaposi's sarcoma lesions. It offers the distinct benefit of effective destruction of multiple lesions in a single session without severe morbidity. PDT should be considered as the first-line treatment of Kaposi's sarcoma, but it also should undergo large clinical trials to fully assess its capabilities
We also recommend Trading Suppliers and Manufacturers of tin etiopurpurin (cas 113471-15-1). Pls Click Website Link as below: cas 113471-15-1 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View